BCI-121
BCI-121 is a substrate-competitive inhibitor targeting the lysine methyltransferase SMYD3. It has been shown to suppress cancer cell proliferation in vitro and demonstrates potential for oncology research, including studies on tumor growth in vivo.
Product Specifications
CAS Number
432529-82-3
Product Name Alternative
BCI 121, BCI121, BCI-121, Inhibitor, HistoneMethyltransferase, Histone Methyltransferase, inhibit, SMYD3
Field of Research
Epigenetics & Chromatin
Purity
99.67% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (11.76 mM) ; DMSO:100 mg/mL (293.93 mM)
Smiles
NC (=O) C1CCN (CC (=O) Nc2ccc (Br) cc2) CC1
Molecular Formula
C14H18BrN3O2
Molecular Weight
340.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M00076-carrier-free 100 µL
Anti-LDL Receptor Rabbit Monoclonal Antibody, Carrier-free
Sign In for Pricing
View Details 
